BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol 2020; 26(28): 3998-4017 [PMID: 32821067 DOI: 10.3748/wjg.v26.i28.3998]
URL: https://www.wjgnet.com/1007-9327/full/v26/i28/3998.htm
(310) (285) (0) (0) (10) (2) (18506) (83)
Number Citing Articles
1
Bo Shen, Gursimran S Kochhar, David T Rubin, Sunanda V Kane, Udayakumar Navaneethan, Charles N Bernstein, Raymond K Cross, Akira Sugita, Jason Schairer, Ravi P Kiran, Philip Fleshner, James T McCormick, André D’Hoore, Samir A Shah, Francis A Farraye, Revital Kariv, Xiuli Liu, Joel Rosh, Shannon Chang, Ellen Scherl, David A Schwartz, Paulo Gustavo Kotze, David H Bruining, Jessica Philpott, Bincy Abraham, Jonathan Segal, Rocio Sedano, Maia Kayal, Stuart Bentley-Hibbert, Dino Tarabar, Sandra El-Hachem, Priya Sehgal, Joseph A Picoraro, Séverine Vermeire, William J Sandborn, Mark S Silverberg, Darrell S Pardi. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. The Lancet Gastroenterology & Hepatology 2022; 7(1) doi: 10.1016/S2468-1253(21)00214-4
2
叶卿 罗. Research Progress of Relapse Factors in Inflammatory Bowel Disease. Advances in Clinical Medicine 2022; 12(07) doi: 10.12677/ACM.2022.127924
3
Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain. Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2024.00001
4
Mi Guo, Yu Zou, Ke Dong, Nan Huang, Zhichao Chen, Chenhui Sun, Pan Chen, Qi Chen, Luxiao Zhu, Yuehua Lv, Kaixin Zhang, Miao Jiang, Yitian Gao, Young-Chang Cho, Qidong Tang, Guang Liang, Di Wu. Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UC. European Journal of Medicinal Chemistry 2025; 289 doi: 10.1016/j.ejmech.2025.117431
5
Xinyue Yang, Min He, Qingqing Tang, Zhihong Wang, De Jin, Xingquan Wu, Yonggang Yang, Dehui Ma, Mengmeng Sun, Tie Li. Assessment of anti-inflammatory efficacy of acupuncture in patients with inflammatory bowel disease: A systematic review and meta-analysis. Complementary Therapies in Medicine 2023; 74 doi: 10.1016/j.ctim.2023.102946
6
Luiz C. Di Stasi. Coumarin Derivatives in Inflammatory Bowel Disease. Molecules 2021; 26(2) doi: 10.3390/molecules26020422
7
Hanin Aljohani, Doaa Anbarserry, Mahmoud Mosli, Amani Ujaimi, Duaa Bakhshwin, Ramu Elango, Sameer Alharthi. High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia. Biomedicines 2025; 13(2) doi: 10.3390/biomedicines13020459
8
Yijie Xie, Qiwen Jiang, Huabing Huang, Xinyuan Zhang, Xiaoyi Zheng, Yunyi Yang, Shige Wang, Jiulong Zhao, Zhaoshen Li. Biomimetic Layered Double Hydroxide-Molybdenum Disulfide Encapsulated with Bovine Serum Albumin: A Multifaceted Nanotherapy for Inflammatory Bowel Disease. Biomaterials Research 2026; 30 doi: 10.34133/bmr.0369
9
Samridhi Lakhanpal, Kanishk Aggarwal, Harmanjit Kaur, Kunal Kanwar, Vasu Gupta, Jill Bhavsar, Rohit Jain. Cardiovascular disease: extraintestinal manifestation of inflammatory bowel disease. Intestinal Research 2025; 23(1) doi: 10.5217/ir.2023.00104
10
Luiz C. Di Stasi. Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs. Pharmaceuticals 2023; 16(4) doi: 10.3390/ph16040511
11
Ming-Yu Jin, Sai-Yin Yu, Er-Feng Wang, Henan Zhang, Jing-Yi Xu, Chen Wang, Long-Qing Li, Jing-Kun Yan. Curcumin-Loaded Lactoferrin/Pectin Core–Shell Structured Microgel Nanoparticles: Dual Regulatory Effects in Alleviating Inflammatory Bowel Disease. Nutrients 2026; 18(6) doi: 10.3390/nu18060921
12
Anish Kumar Reddy Meda, Fremita Chelsea Fredrick, Urvashi Rathod, Priyanshi Shah, Rohit Jain. Cardiovascular Manifestations in Inflammatory Bowel Disease. Current Cardiology Reviews 2024; 20(1) doi: 10.2174/011573403X256094231031074753
13
Hengyi Yu, Dongyan Li, Dong Xiang, Xiping Li, Lu Liu, Dong Liu, Xuepeng Gong. Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cells. Heliyon 2023; 9(3) doi: 10.1016/j.heliyon.2023.e13870
14
Yuqian Feng, Jiamin Lu, Jing Jiang, Menglei Wang, Kaibo Guo, Shengyou Lin. Berberine: Potential preventive and therapeutic strategies for human colorectal cancer. Cell Biochemistry and Function 2024; 42(4) doi: 10.1002/cbf.4033
15
Zezheng Wang, Jing Tang, Shiying Wang, Haiyan Zhang. Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis on hemodialysis for end-stage renal failure: a case report. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1616425
16
Yi-li Wang, Hai-yan Zhu, Xi-qian Lv, Xing-ying Ren, Ying-chun Peng, Jin-yu Qu, Xue-fang Shen, Ran Sun, Meng-lu Xiao, Hong Zhang, Zhao-hui Chen, Peng Cong, Gabriele Sansevero. Electroacupuncture Zusanli (ST36) Relieves Somatic Pain in Colitis Rats by Inhibiting Dorsal Root Ganglion Sympathetic-Sensory Coupling and Neurogenic Inflammation. Neural Plasticity 2023; 2023 doi: 10.1155/2023/9303419
17
Jiayi Jin, Lijun Yue, Maoru Du, Feng Geng, Xue Gao, Yuming Zhou, Qianqian Lu, Xiaohong Pan. Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application. MedComm 2025; 6(5) doi: 10.1002/mco2.70194
18
Sara Ibgui, Daisy Lints, Simon Milling. From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways. Pharmacological Research 2025; 222 doi: 10.1016/j.phrs.2025.108059
19
Kathryn Hawa, Ross Maltz, Amy Donegan, Vinay Prasad, Jennifer L. Dotson, Brendan Boyle, Hilary K. Michel. Postcolectomy Enteritis in a Pediatric Patient With Ulcerative Colitis. JPGN Reports 2022; 3(4) doi: 10.1097/PG9.0000000000000255
20
Boualem Sendid, Marjorie Cornu, Camille Cordier, Julie Bouckaert, Jean Frederic Colombel, Daniel Poulain. From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health. Autoimmunity Reviews 2024; 23(2) doi: 10.1016/j.autrev.2023.103486
21
Naoimh Herlihy, Roger Feakins. Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?. United European Gastroenterology Journal 2022; 10(5) doi: 10.1002/ueg2.12242
22
Rachele Del Sordo, Vassilios Lougaris, Gabrio Bassotti, Alessandro Armuzzi, Vincenzo Villanacci. Therapeutic agents affecting the immune system and drug-induced inflammatory bowel disease (IBD): A review on etiological and pathogenetic aspects. Clinical Immunology 2022; 234 doi: 10.1016/j.clim.2021.108916
23
Gabriela R. Batista, Ana E. V. Quaglio, Luiz D. Almeida Junior, Ligia Y. Sassaki, Luiz C. Di Stasi. Dietary Supplementation with Green Fruits of Musa spp. AAA Ameliorates Acute, Subchronic, and Chronic Intestinal Inflammation with Relapse Induced by Trinitrobenzenesulfonic Acid in Rats. ACS Food Science & Technology 2025; 5(7) doi: 10.1021/acsfoodscitech.5c00285
24
Huayue Zhang, Miaomiao Wu, Hang Thu Ta, Zhi Ping Xu, Run Zhang. Recent Development and Applications of Sensors for the Detection of Matrix Metalloproteinases. Advanced Materials Technologies 2023; 8(9) doi: 10.1002/admt.202201786
25
Pan Luo, Huiying Qiu, Yushan Yang, Jiaqi Wu, Xianmin Song, Guorong Fan, Gaolin Liu, Junwei Gao. Gilteritinib-induced severe immune-related enteritis: a possible case report. Anti-Cancer Drugs 2023; 34(7) doi: 10.1097/CAD.0000000000001470
26
José Maurício, Inês Domingues. Pattern Recognition and Image Analysis. Lecture Notes in Computer Science 2023; 14062 doi: 10.1007/978-3-031-36616-1_42
27
Sara El Ouali, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2026;  doi: 10.1016/B978-0-443-29172-2.00019-3
28
Raffaele Borghini, Mariavittoria Vescovo, Carla Giordano, Giuseppe Donato, Antonio Picarelli. Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis. Inflammatory Bowel Diseases 2021; 27(6) doi: 10.1093/ibd/izab036
29
Faisal Alshammari, Hayder M. Al-Kuraishy, Mustafa M. Shokr, Marios Papadakis, Athanasios Alexiou, Gaber El-Saber Batiha. Enterogenic dementia: defining the gut–brain axis and the role of inflammatory bowel disease in cognitive impairment. Inflammopharmacology 2025; 33(11) doi: 10.1007/s10787-025-01940-6
30
Xinyue Yang, Mengmeng Sun, Min He, Zhihong Wang, Qingqing Tang, Tie Li. Acupuncture for inflammatory bowel disease: A protocol for systematic review and meta-analysis. Medicine 2022; 101(49) doi: 10.1097/MD.0000000000032236
31
Penghang Lin, Jin Hua, Zuhong Teng, Chunlin Lin, Songyi Liu, Ruofan He, Hui Chen, Hengxin Yao, Jianxin Ye, Guangwei Zhu. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01193-5
32
Mengjiao Zhou, Bing Pei, Peipei Cai, Chengxue Yi, Francis Atim Akanyibah, Changkun Lyu, Fei Mao. Human umbilical cord mesenchymal stem cell-derived exosomes repair IBD by activating the SIRT1-FXR pathway in macrophages. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04365-8
33
Mona A. Raslan, Rehab F. Abdel-Rahman, Hany M. Fayed, Marawan A. Elbaset, Rehab F. Taher. Unveiling phytoconstituents and the anti-inflammatory potential of Crassula tetragona L. in ulcerative colitis: A focus on the PPARγ/SIRT1 axis. Inflammopharmacology 2026; 34(1) doi: 10.1007/s10787-025-02049-6
34
Pascal Petit, Ariane Leroyer, Sylvain Chamot, Mathurin Fumery, Vincent Bonneterre. Farming Activities and Risk of Inflammatory Bowel Disease: A French Nationwide Population-based Cohort Study. Journal of Crohn's and Colitis 2024; 18(9) doi: 10.1093/ecco-jcc/jjae050
35
Sena Nur Kumral, Beyza Katırcıoğlu, Nasminel Tekin, Semiha Nur Öztürk, Feride Ayyıldız. İnflamatuvar Bağırsak Hastalığı Tanısı Alan Yetişkin Bireylerde Mikrobiyota Farkındalığı ve Akdeniz Diyetine Uyumun Değerlendirilmesi. Black Sea Journal of Health Science 2024; 7(1) doi: 10.19127/bshealthscience.1362512
36
Cristina Bauset, Lluis Lis-Lopez, Sandra Coll, Laura Gisbert-Ferrándiz, Dulce C. Macias-Ceja, Marta Seco-Cervera, Francisco Navarro, Juan V. Esplugues, Sara Calatayud, Dolores Ortiz-Masia, Maria D. Barrachina, Jesús Cosín-Roger. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis. Biomedicines 2022; 10(3) doi: 10.3390/biomedicines10030532
37
Liqing Yang, Xi Zhong, Hao Yang, Qin Wu, Yuping Gong, Bo Wang. Pneumatosis cystoides intestinalis associated with etoposide in hematological malignancies: a case report and a literature review. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02219-8
38
Mengjiao Zhou, Danfeng Wang, Xiang Li, Ying Cao, Chengxue Yi, Dickson Kofi Wiredu Ocansey, Yuling Zhou, Fei Mao. Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1016836
39
Chunying Sun, Jingwen Zhu, Xueyuan Sun, Zhidong Zhang, Yantong Sun, Yan Jin, Tao Wu. Targeting the human gut microbiome: a comparative review of probiotics, prebiotics, synbiotics, and postbiotics. Journal of Advanced Research 2025;  doi: 10.1016/j.jare.2025.12.032
40
Mingcong Ding, Zhenshan Wang, Linyu Xu, Juan Shi, Shuwei Chen, Qiang Li, Zixian Liu. The dual role of lipoteichoic acid: from immune modulation to therapeutic applications in disease treatment. Inflammopharmacology 2026; 34(4) doi: 10.1007/s10787-026-02130-8
41
Miljana Glazar, Sonia Facchin. Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy. Academia Nutrition and Dietetics 2025; 2(4) doi: 10.20935/AcadNutr7951
42
Geeta Kulkarni, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2026;  doi: 10.1016/B978-0-443-29172-2.00002-8
43
Yong Zhang, Han Qiao, Yuxin Cao, Meng Zhang, Xuelei Zhang, Peng Li. Protective Effects of Aucubin in DSS-Induced Colitis: Modulation of Inflammatory Pathways, Intestinal Barrier Integrity, and Gut Microbiota. Foods 2025; 14(21) doi: 10.3390/foods14213648
44
Shun Okamura, Chie Bujo, Eisuke Amiya, Ken Kurokawa, Masaru Hatano, Junichi Ishida, Masaki Tsuji, Sozaburo Ihara, Keita Murakami, Chihiro Shiomi, Yoku Hayakawa, Mitsuhiro Fujishiro, Minoru Ono, Issei Komuro. The first case report of de novo Crohn's disease after heart transplantation successfully treated with ustekinumab. Journal of Cardiology Cases 2024; 29(4) doi: 10.1016/j.jccase.2023.12.005
45
Zhi Wang, Yu Chang, Haibo Sun, Yuqin Li, Tongyu Tang. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review). Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14390
46
Tao Zhang, Binbo He, Chao Lan, Jie Liu, Qingyu Zeng, Wenfeng Pu, Lifeng Zhou, Qian Zhou, Dan Hu, Yanan Chen, Yiming Peng, Guobing Li, Qing Wang, Long Chen, Zonghan Du, Shiqing Li, Xiaobo Tang, Jian Chen, Chuanxing Xiao. Predicting Risk of Post-Treatment Relapse in Patients with Inflammatory Bowel Disease Based on Intestinal Microbiota. Journal of Inflammation Research 2025;  doi: 10.2147/JIR.S558136
47
Jia Wang, Yuying Shi, Bei Mao, Biheng Zhang, Jie Yang, Zhijian Hu, Weifang Liao. Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids. Applied Materials Today 2024; 36 doi: 10.1016/j.apmt.2024.102078
48
Jie Lin, Jiani Yang, Leqi Cui, Ravinder Nagpal, Prashant Singh, Gloria Salazar, Qinchun Rao, Ye Peng, Quancai Sun. Sturgeon-derived peptide LLLE alleviates colitis via regulating gut microbiota and its metabolites. Current Research in Food Science 2024; 9 doi: 10.1016/j.crfs.2024.100898
49
Makoto Nakajima, Yasushi Iwao, Koji Okabayashi, Yae Kanai, Masayuki Shimoda. Pathological characteristics of inflammatory bowel diseases. Journal of Medical Ultrasonics 2025; 52(2) doi: 10.1007/s10396-025-01520-9
50
Dragana Jovanovic, Rada Miskovic, Aleksandra Plavsic, Sara Radovic, Ljudmila Nagorni-Obradovic, Dragan Popovic, Milos M. Nikolic, Branka Bonaci-Nikolic. Antineutrophil Cytoplasmic Autoantibodies Specific to Bactericidal/Permeability-Increasing Protein: A Cross-Road Between Prolonged Gram-Negative Bacterial Infections and Ulcerative Colitis/Primary Sclerosing Cholangitis. Diagnostics 2025; 15(18) doi: 10.3390/diagnostics15182309
51
Naoual El Menyiy, Aicha El Allam, Sara Aboulaghras, Imane Jaouadi, Saad Bakrim, Nasreddine El Omari, Mohammad Ali Shariati, Alevtin Miftakhutdinov, Polrat Wilairatana, Mohammad S. Mubarak, Abdelhakim Bouyahya. Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds. Biomedicine & Pharmacotherapy 2022; 151 doi: 10.1016/j.biopha.2022.113158
52
Ana Elisa Valencise Quaglio, Thais Gagno Grillo, Ellen Cristina Souza De Oliveira, Luiz Claudio Di Stasi, Ligia Yukie Sassaki. Gut microbiota, inflammatory bowel disease and colorectal cancer. World Journal of Gastroenterology 2022; 28(30): 4053-4060 doi: 10.3748/wjg.v28.i30.4053
53
Cheng-Jun Li, Yi-Kai Wang, Shun-Ming Zhang, Mu-Dan Ren, Shui-Xiang He. Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast. World Journal of Gastroenterology 2023; 29(42) doi: 10.3748/wjg.v29.i42.5764
Abstract(0) |  Core Tip(0) |  Full Article(HTML)(0) | Times Cited (1) | Total Visits (0) | Open
54
Jiaying Wu, Xuwen Mao. Miniature rose alleviates inflammatory bowel disease in mice by modulating gut microbiota, inhibiting TLR4, enhancing tight junction proteins, and promoting metabolism. Frontiers in Microbiology 2026; 16 doi: 10.3389/fmicb.2025.1721294
55
Samin Zamani, Sima Besharat, Nasser Behnampour, Armina Behnam, Negar Asgari, Nazanin Mortazavi. Bacteroides fragilis in saliva: investigating links with ulcerative colitis. Brazilian Journal of Microbiology 2024; 55(4) doi: 10.1007/s42770-024-01484-x
56
Su Zhou, Jiong Tang, Yu Wang. Trichuris suis ova in inflammatory bowel disease-clinical challenges and translational pathways. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1611690
57
Guoming Chen, Qing Ren, Zilan Zhong, Qianfan Li, Zhiqiang Huang, Cheng Zhang, Hongchao Yuan, Zixin Feng, Bonan Chen, Ning Wang, Yibin Feng. Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1431747
58
Saray Mesonero-Cavia, Marta Freixas-Bermejo, Marina Álvarez-Beltran, Susana Redecillas-Ferreiro, Vanessa Cabello-Ruiz, Judith Raya-Muñoz, Maria Mercadal-Hally, Andrea Martin-Nalda, Oscar Segarra-Cantón. De novo Crohn’s Disease Treated with Ustekinumab in a Pediatric Liver Transplant Recipient with Tyrosinemia: A Case Report. Case Reports in Gastroenterology 2026; 20(1) doi: 10.1159/000551716
59
Bo Shen. Corrective Endoscopy and Surgery in Inflammatory Bowel and Colorectal Diseases. 2025;  doi: 10.1016/B978-0-323-83439-1.00001-9
60
Junfeng Zou, Chen Liu, Shu Jiang, Dawei Qian, Jinao Duan, Anthony R. Richardson. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infection and Immunity 2021; 89(9) doi: 10.1128/IAI.00014-21
61
Shouzhi Zhou, Zhao Yang, Jiaxin Liu, Maojuan Ran. TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation. Immunology Letters 2023; 255 doi: 10.1016/j.imlet.2023.02.005
62
Amir Barkhodari, Kate E. Lee, Min Shen, Bo Shen, Qingping Yao. Inflammatory bowel disease: focus on enteropathic arthritis and therapy. Rheumatology and Immunology Research 2022; 3(2) doi: 10.2478/rir-2022-0012
63
Min Wang, Jingyan Shi, Chao Yu, Xinyi Zhang, Gaoxin Xu, Ziyan Xu, Yong Ma. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298186
64
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, Chuyun Yan, Yu Wang, Qionglin Liang, John Y. L. Chiang, Shuxin Han. Interactive Relationships between Intestinal Flora and Bile Acids. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158343
65
Yulai Yin, Xiaoyu Zhang. The causal association between inflammatory bowel disease and breast cancer: a bidirectional two-sample Mendelian randomization study. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1392341
66
Yuou Ying, Mengyuan Shen, Jinhan Chen, Tongfei Feng, Zejiong Li, Zhekai Ying, Dongdong Yang, Ruyi Ju, Jiannong Wu. Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1873829
67
Willie Mohammed Johnson, Byron P. Vaughn, Nicholas Lim. Diagnosis and management of de novo inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series. Frontiers in Transplantation 2025; 3 doi: 10.3389/frtra.2024.1483943
68
Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2026;  doi: 10.1016/B978-0-443-29172-2.00029-6
69
Cheng-Jun Li, Yi-Kai Wang, Shun-Ming Zhang, Mu-Dan Ren, Shui-Xiang He. Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast. World Journal of Gastroenterology 2023; 29(42): 5751-5767 doi: 10.3748/wjg.v29.i42.5751
70
Dandan Zeng, Weijie Ren, Bo Zhao, Yuanyuan Li, Jinlong Jiao, Tianlu Mo. Glycyrrhiza pallidiflora Polysaccharide Ameliorates DSS-Induced Colitis by Protecting Intestinal Barrier Integrity. Cell Biochemistry and Biophysics 2025; 83(3) doi: 10.1007/s12013-025-01765-8
71
Melanie S. Matos, María Ángeles Ávila-Gálvez, Antonio González-Sarrías, Nuno-Valério Silva, Carolina Lage Crespo, António Jacinto, Ana Teresa Serra, Ana A. Matias, Cláudia Nunes dos Santos. Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management. Food & Function 2024; 15(18) doi: 10.1039/D4FO01446D
72
Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, Andrea Buda, Brigida Barberio, Fabiana Zingone, Nicola Vitulo, Edoardo Vincenzo Savarino. Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota. Digestive and Liver Disease 2026; 58(1) doi: 10.1016/j.dld.2025.11.014
73
Dalia M. Mabrouk, Sekena H. Abdel‑Aziem, Soad M. Eweida, Kawkab A. Ahmed, Amany A. Sleem, Ahmed A. Hamed, Dalia A. Youssef, Aida I. El makawy. Microencapsulation-driven synergy of krill oil and Streptococcus thermophilus in attenuating of colonic inflammation, apoptosis and oxidative stress in a murine model of ulcerative colitis. Food Production, Processing and Nutrition 2026; 8(1) doi: 10.1186/s43014-026-00398-5
74
Maryam Ghasemi‐Dehnoo, Zahra Lorigooini, Hossein Amini‐Khoei, Milad Sabzevary‐Ghahfarokhi, Mahmoud Rafieian‐Kopaei. Quinic acid ameliorates ulcerative colitis in rats, through the inhibition of two TLR4‐NF‐κB and NF‐κB‐INOS‐NO signaling pathways. Immunity, Inflammation and Disease 2023; 11(8) doi: 10.1002/iid3.926
75
Taylor M. Halsey, Anusha S. Thomas, Tomo Hayase, Weijie Ma, Hamzah Abu-Sbeih, Baohua Sun, Edwin Roger Parra, Zhi-Dong Jiang, Herbert L. DuPont, Christopher Sanchez, Rawan El-Himri, Alexandria Brown, Ivonne Flores, Lauren McDaniel, Miriam Ortega Turrubiates, Matthew Hensel, Dung Pham, Stephanie S. Watowich, Eiko Hayase, Chia-Chi Chang, Robert R. Jenq, Yinghong Wang. Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis. Science Translational Medicine 2023; 15(700) doi: 10.1126/scitranslmed.abq4006
76
Keiichi Tominaga, Takeshi Sugaya, Takanao Tanaka, Mimari Kanazawa, Makoto Iijima, Atsushi Irisawa. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.582291
77
Xueyi Ren, Jun Xu, Xiaolei Zhao. Global Trends and Future Projections in the Burden of Inflammatory Bowel Disease Among Adolescents and Young Adults (15–49 Years) From 1990 to 2021. JGH Open 2025; 9(9) doi: 10.1002/jgh3.70282
78
Qingtong Li, Yanqi Kou, Mingcheng Zhang, Chunyi Wu, Rongfo Mi, Wantong Jiang, Yufei Cheng, Lei Ge, Ke Yang, Zhe Huang, Yuan Tian, Botao Luo, Yanping Ha, Wanyi Yin, Wei Guo, Wenwei Zhu, Jun Liu, Shicai Ye, Yijie Weng, Jiayuan Wu, Yuping Yang. Sex-specific and socioeconomic disparities in the global burden of inflammatory bowel disease in 204 countries, 1990–2021: projections to 2050. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1673212
79
Michele A. Serafini, Ana H. Paz, Natalia S. Nunes. Cholinergic immunomodulation in inflammatory bowel diseases. Brain, Behavior, & Immunity - Health 2022; 19 doi: 10.1016/j.bbih.2021.100401
80
Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo, Fernando Gomollón. Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers 2023; 15(3) doi: 10.3390/cancers15030871
81
Lan Yang, Han Gao, Dacheng Liu. Advance on establishment of pathological model of ulcerative colitis. Frontiers in Veterinary Science 2025; 12 doi: 10.3389/fvets.2025.1618260
82
Abdelrahim Alqudah, Esam Qnais, Omar Gammoh, Yousra Bseiso, Mohammed Wedyan, Mohammad Alqudah, Amani A. Harb, Alaa A. A. Aljabali, Anwar M. Alnakhli, Sireen Abdul Rahim Shilbayeh. Modulation of inflammatory, oxidative, and apoptotic pathways by cirsimaritin in colitis: A mechanistic approach. Advances in Traditional Medicine 2025; 25(4) doi: 10.1007/s13596-025-00832-y
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.